In Vitro Study of the Effect of Gadolinium Contrast on Fibrocytes
NCT02512796 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2015-07-31
Summary
Gadolinium contrast agents are frequently administered for MRI imaging. Very little is known of its toxicity outside of patients with reduced renal function.
Conditions
- Gadolinium Toxicity
Interventions
- DRUG
-
Gadolinium contrast dye
Gadolinium contrast dye administered during MRI
Sponsors & Collaborators
-
University of Virginia
lead OTHER
Principal Investigators
-
Sundararaman Swaminathan, MD · University of Virginia
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
Post-marketing Safety Study in Participants of All Pathologies Who Receive Gadolinium-Based Contrast Agents (GBCAs) for Contrast-Enhanced Magnetic Resonance Imaging (MR) Examination
NCT03455283 ·Status: COMPLETED
-
P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
NCT02633501 ·Status: COMPLETED ·Phase: PHASE2
-
Infiltration of Gadolinium Injection in Brain MR Scans Using Artificial Intelligence
NCT05235646 ·Status: COMPLETED
-
Glymphatic Kinetics In Healthy Adult Volunteers
NCT03218111 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging
NCT01660841 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Retention of Gadolinium in Bone
NCT01853163 ·Status: COMPLETED ·Phase: NA
-
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
NCT03270059 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging
NCT00623467 ·Status: COMPLETED ·Phase: PHASE3
-
Glymphatic Pathway in Brain Imaging
NCT05035251 ·Status: RECRUITING
-
Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
NCT04846257 ·Status: COMPLETED
-
Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)
NCT03986138 ·Status: COMPLETED ·Phase: PHASE3
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
NCT06103201 ·Status: RECRUITING ·Phase: PHASE1
-
Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children
NCT00392730 ·Status: COMPLETED
-
Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
NCT04307186 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems
NCT05915702 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand 11C-MK-3168 and the Blocking of the Retention of the Ligand in the Human Brain by JNJ-42165279
NCT02169973 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Rifaximin in Minimal Hepatic Encephalopathy
NCT01069133 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
NCT02947022 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.
NCT00764387 ·Status: COMPLETED ·Phase: PHASE4
-
Magnetic Resonance (MR) Spectroscopy and Diffusion Tensor Imaging in Determining Brain Injury and Subsequent Clinical Outcome in Patients of Moderate Brain Trauma
NCT00760903 ·Status: WITHDRAWN
-
Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison
NCT07272616 ·Status: RECRUITING
-
Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging
NCT00709852 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070
NCT03270579 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility of Gadolinium Contrast Reduced Brain MRI: the Potential of Deep Learning
NCT06462924 ·Status: WITHDRAWN ·Phase: PHASE1
-
Blood-brain Barrier Permeability Study in Adults With Meningitis
NCT02902588 ·Status: TERMINATED ·Phase: NA